[Jazz music] is the art of harnessing individual talents through collaboration, improvisation and constant evolution. It’s unique in its sound and composition, and the connections it…
In Conversation
BioDuro 4.0 is really about explosive growth. Tangibly, in three years, we are looking to double our current size in both China and the US
GE Healthcare is committed to the region, so we see the challenges that Libya, Sudan and Egypt are facing as temporary and an opportunity to improve…
The local Chinese industry has a history of working with generics and biosimilars, which is a matter of ‘reverse-engineering’. We are working to change this focus…
As the science is moving rapidly, Janssen Egypt is focusing on ongoing medical education, by bringing innovative new ideas to the physicians and meeting their needs…
We need to look beyond French borders and have been actively looking for investors in the US as this is where the relevant institutional investors are
With the future evolution of European medical device regulation, I see an opportunity for the company
In 2018 alone we have invested 50 percent of our profits into setting up new sales lines in order to fulfil the local demand but also…
Especially in a young and distinctive company like Aspen, I consider it essential to be recruiting personnel with the right attitude that reflects the dynamism, entrepreneurialism…
The TREM-1 pathway can be used to develop treatments for different indications besides septic shock, including cardiovascular diseases and chronic inflammatory conditions, which could be interesting…
Unlike competitor generics companies now struggling to find profitability, we remained focused on hospitals and have a very lean operation, with revenues of over EUR 50…
We are focusing our efforts as a company to grow our dermatological portfolio and have divested other products not related to this area
